Quality Failures at Generic Drug Maker Put Patients at Risk, FDA Warns July 10, 2019 By Anna Edney and Jef Feeley Manufacturing problems at Akorn Inc.’s New Jersey plant “pose a risk to patients,” U.S. regulators have warned the embattled generic-drug...
